To the Seminar --;Aetiology and Epidemiology --;Markovian Models as a Tool in Epidemiology --;Familial Adenomatous Polyposis: Current Status in Switzerland --;Down-Regulation of a Cell-Surface Glycoprotein Correlated with Rearrangement of Chromosome 1 in Human Breast Cancer Cells --;Gastric Cancer in Hawaii Japanese: A Family Study --;Increased Number of Multiple Melanomas in Sporadic and Familial Variants of Dysplastic Naevus Syndrome --;Family History in Clinical Trials: Experience of the IBCSG and the SAKK --;Aetiology and Epidemiology --;Report of Rapporteur --;Lynch Syndromes --;Lynch Syndromes I and II --;Natural History, Diagnosis and Control Strategies --;Cost-Benefit Implications in the Surveillance of Lynch Syndrome Subjects --;Treatment --;Is Endoscopy Still Controversial in Secondary Prevention of Colon Cancer? --;Preventive Surgery --;Desmoids in Gardner's Syndrome: A Challenge for Surgeons --;Radiation and Cancer Prevention --;Chemoprevention --;Familial Cancer Control --;Cancer Prevention Through Genetic Counselling --;Identification of Persons at High Risk for Cancer: A Delay in UV-lnduced DNA Repair is Correlated with Multiple Skin Cancer --;The Nurse's Role in Familial Cancer --;Screening for Colorectal Neoplasia in Families --;Risk Assessment in Hereditary Breast Cancer --;A Screening Programme for Medullary Thyroid Carcinoma and Breast Cancer for Families at High Risk --;Familial Cancer Control --;Report of Rapporteur --;A Clinical Study of Familial Cancer in Japan --;DNA Diagnosis in Families with Hereditary Forms of Cancer --;UICC Strategy Meeting --;Familial Cancer Among Cancer Patients Registered at the Aichi Cancer Registry --;Heterogeneity of Aggregation of Familial Cancer --;Report of the First UICC Strategy Meeting on Familial Cancer.
This monograph contains the contributions of a seminar on familial cancer. All types of cancer show a tendency to aggregate in families. Cancer families can be identified by taking a family history in cancer patients. This method is useful for detecting cancer genes and determining which persons carry a high risk for cancer and who may thus benefit frompreventive measures such as screening and chemoprevention.